Albepro Nasal Spray (Mometasone Furoate (Unformulated))

Adult use

For allergic rhinitis, adults and adolescents aged 12 years and older should use 2 sprays in each nostril once a day (total daily dose 0.2 mg). When symptoms are relieved, the maintenance dose may be reduced to 1 spray in each nostril once a day (total daily dose 0.1 mg). It is possible to increase the dose to a maximum of 4 sprays in each nostril once a day (total daily dose 0.4 mg), and the dose should be reduced when symptoms are relieved.

Child use

For allergic rhinitis, children aged 2 to 11 years should use 1 spray in each nostril once a day (total daily dose 0.1 mg).

This medication should not be used in certain patients. For example, patients who are allergic to this drug or its components, patients with untreated infections of the nasal mucosa, those who have recently undergone nasal surgery or have wounds in the nasal area, and children under 2 years of age should not use this medication. There are also patients who require caution in using this medication. Patients with active or latent tuberculosis, systemic infections, ocular herpes, those who frequently experience nosebleeds, patients who may have been exposed to chickenpox or measles, those with specific nasal diseases, and women who are pregnant or breastfeeding should use this medication with caution. Using this medication may lead to various side effects such as headaches, viral infections, pharyngitis, nosebleeds, coughing, and upper respiratory infections. Some patients may experience side effects severe enough to discontinue the medication, so caution is necessary. Rarely, serious hypersensitivity reactions such as allergic reactions or anaphylaxis may occur; in such cases, the use should be stopped immediately and a physician consulted. Long-term high-dose use may lead to systemic side effects, and regular examinations are necessary to check for changes in the nasal mucosa. Moreover, if symptoms of infection worsen or new symptoms appear, medical advice should be sought immediately. This medication may pose risks to both the fetus and the mother during pregnancy, so it should only be used after consultation with a physician, and caution is also advised for breastfeeding women. When administering this medication to children, there is a risk of growth delays, so regular monitoring of growth status is necessary, and caution is advised against using this medication in children under 2 years of age due to unconfirmed safety. In the elderly, it should be used carefully, considering the decline in physical function. This medication may interact with other drugs; caution is advised, especially when used in conjunction with CYP3A4 inhibitors, as this may increase the risk of systemic side effects. Before use, the container should be shaken well, and a test spray should be performed, taking care not to spray directly into the eyes or the nasal septum. Keep out of reach of children, and in case of overdose, observation rather than specific treatment is necessary. If blurriness or visual impairment occurs, consult an ophthalmologist immediately. There are no reports of effects on driving or operating machinery, but caution should be exercised if unusual symptoms occur.

Serious side effects

• Urticaria
• severe swelling (angioedema)
• difficulty breathing
• severe allergic reactions (anaphylaxis)
• nosebleeds
• headaches
• bronchospasm
• dyspnea
• generalized flushing
• angioedema

Mild side effects

Headaches, viral infections, pharyngitis, nosebleeds/bloody-colored mucus, coughing, upper respiratory infections, dysmenorrhea, musculoskeletal pain, sinusitis, vomiting, arthralgia, asthma, bronchitis, chest pain, conjunctivitis, diarrhea, dyspepsia, otalgia, cold symptoms, myalgia, nausea, rhinitis, diarrhea, nasal inflammation, otitis media, wheezing, skin trauma, rash such as urticaria, nasal symptoms (irritation, itching, dryness, pain, redness, discomfort)

This medication may be sensitive to air and humidity, so it should be stored in a tightly closed container. The appropriate storage temperature is room temperature between 2°C to 25°C, avoiding very hot or very cold places.

Appearance

A white or nearly white opaque suspension packaged in a container for nasal spraying, releasing a certain amount each time.

Package unit

18g/bottle